Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
{{output}}
Background: Pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) is strongly associated with favorable outcome. We examined the utility of serial circulating tumor DNA (ctDNA) testing for predicting pCR and risk o... ...
